Suppr超能文献

全身麻醉与长期神经毒性。

General anesthetics and long-term neurotoxicity.

作者信息

Perouansky M

机构信息

Department of Anesthesiology, University of Wisconsin School of Medicine, B6/319 Clinical Science Center, 600 Highland Ave., Madison, WI, USA.

出版信息

Handb Exp Pharmacol. 2008(182):143-57. doi: 10.1007/978-3-540-74806-9_7.

Abstract

We do not know how general anesthetics cause their desired effects. Contrary to what has been thought until relatively recently, the clinical state of anesthesia consists of multiple components that are mediated via interaction of the anesthetic drugs with different targets on the molecular-cellular, the network, and the structural-anatomical levels. The molecular targets by which some of these drugs induce the different components of "anesthesia" may be rather specific: discrete mutations of single amino acids in specific proteins profoundly affect the ability of certain anesthetics to achieve specific endpoints. Despite this potential specificity, inhalational anesthetics are present in the body at very high concentrations during surgical anesthesia. Due to their lipid solubility, general anesthetics dissolve in every membrane, penetrate into every organelle, and can interact with numerous cellular structures in multiple ways. A priori, it is therefore not unreasonable to assume that these drugs have the potential to cause insidious changes in the body other than those acute and readily apparent ones that we routinely monitor. Some changes may wane within a short time after removal of the drug (e.g., the suppression of immune cell function). Others may persist after complete removal of the drug and even become self-propagating [e.g., beta-oligomerization of proteins (Eckenhoff et al. 2004)], still others may be irreversible [e.g., the induction of apoptosis in the CNS (Jevtovic-Todorovic et al. 2003)] but of unclear significance. This article will focus on evidence for anesthetic toxicity in the central nervous system (CNS). The CNS appears to be susceptible to anesthetic neurotoxicity primarily at the extremes of ages, possibly via different pathways: in the neonate, during the period of most intense synaptogenesis, anesthetics can induce excessive apoptosis; in the aging CNS subtle cognitive dysfunction can persist long after clearance of the drug, and processes reminiscent of neurodegenerative disorders may be accelerated (Eckenhoff et al. 2004). At all ages, anesthetics affect gene expression-regulating protein synthesis in poorly understood ways. While it seems reasonable to assume that the vast majority of our patients completely restore homeostasis after general anesthesia, it is also time to acknowledge that exposure to these drugs has more profound and longer lasting effects on the brain than heretofore imagined.

摘要

我们尚不清楚全身麻醉药是如何产生其预期效果的。与直到最近人们所认为的情况相反,麻醉的临床状态由多个成分组成,这些成分是通过麻醉药物与分子 - 细胞、网络以及结构 - 解剖学水平上的不同靶点相互作用来介导的。其中一些药物诱导“麻醉”不同成分的分子靶点可能相当特异:特定蛋白质中单个氨基酸的离散突变会深刻影响某些麻醉药达到特定终点的能力。尽管有这种潜在的特异性,但在手术麻醉期间,吸入性麻醉药在体内的浓度非常高。由于其脂溶性,全身麻醉药可溶解于每一层膜,渗透到每一个细胞器,并能以多种方式与众多细胞结构相互作用。因此,从先验角度来看,假设这些药物除了我们常规监测的那些急性且易于察觉的变化外,还可能在体内引起隐匿性变化并非不合理。有些变化在药物去除后短时间内可能会减弱(例如免疫细胞功能的抑制)。其他变化在药物完全去除后可能会持续,甚至会自我传播[例如蛋白质的β - 寡聚化(埃肯霍夫等人,2004年)],还有一些可能是不可逆的[例如中枢神经系统中细胞凋亡的诱导(耶夫托维奇 - 托多罗维奇等人,2003年)],但其意义尚不清楚。本文将聚焦于中枢神经系统(CNS)中麻醉药毒性的证据。中枢神经系统似乎主要在年龄极端阶段易受麻醉药神经毒性影响,可能通过不同途径:在新生儿期,在突触发生最活跃的时期,麻醉药可诱导过度的细胞凋亡;在衰老的中枢神经系统中,轻微的认知功能障碍在药物清除后可能会持续很长时间,并且类似于神经退行性疾病的过程可能会加速(埃肯霍夫等人,2004年)。在所有年龄段,麻醉药以人们了解甚少的方式影响基因表达 - 调节蛋白质合成。虽然假设绝大多数患者在全身麻醉后能完全恢复内环境稳态似乎是合理的,但现在也该承认,接触这些药物对大脑的影响比以往想象的更为深刻和持久。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验